PTC Therapeutics (PTCT) has announced that the US Food and Drug Administration (FDA) has approved Evrysdi (risdiplam), the first at-home, orally administered treatment …
Here’s a glimpse into this hedge fund guru’s Q2 moves that reeled back in three biotech players.
PTCT rises back amid hope for approval in nmDMD; DXCM suffers from new competition in diabetes market.
PTC Therapeutics, Inc. (NASDAQ:PTCT) shares tumbled nearly 16% this morning after investors learned that the company’s Ataluren Confirmatory Trial (ACT CF) in nonsense mutation cystic …
Both PTC Therapeutics, Inc. (NASDAQ:PTCT) and NVIDIA Corporation (NASDAQ:NVDA) stocks are on the rise today following CHMP’s recommendation and positive earnings release, respectively.
It’s a good day to be an investor in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT), after the the Committee for Medicinal Products for …
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
Healthcare analysts are weighing in on ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) and PTC Therapeutics, Inc. (NASDAQ:PTCT), as the stocks turned extremely volatile today.
PTC Therapeutics, Inc. (NASDAQ:PTCT) investors are having a rough morning after the drug maker announced that the FDA has denies the company’s appeal of the Refuse …
Analysts are weighing in on medical test maker GenMark Diagnostics, Inc (NASDAQ:GNMK) and biotech firm PTC Therapeutics, Inc. (NASDAQ:PTCT), as both stocks hit their 52-week …